Perry F. Renshaw
No Rating Available
(Learn About Our Rating System)

Perry F. Renshaw, MD, PhD, MBA

Languages spoken: English

Perry Renshaw, MD, PhD, MBA, is a graduate of the University of Pennsylvania Perelman School of Medicine in Philadelphia, PA. He also completed his PhD in Biophysics at the University of Pennsylvania and his MBA at the McCallum Graduate School of Business, Bentley College, in Waltham, MA. Dr. Renshaw serves as the Medical Director of the VISN 19 Mental Illness Research, Education and Clinical Center (MIRECC) at the Salt Lake City Veterans Affairs Medical Center. His training as a biophysicist and psychiatrist has led to a primary research interest in the use of multinuclear magnetic resonance spectroscopy (MRS) neuroimaging to identify changes in brain chemistry associated with psychiatric disorders and substance abuse. Over the past 20 years, he has conducted more than 1,000 MRS brain scans of individuals with mood disorders, with the goal of characterizing the cross-sectional and longitudinal alterations in brain chemistry associated with mood disorders and their treatment. As Professor in the Department of Psychiatry, he has a notable publication record having served as an author on more than 300 publications. His research projects have been funded by the NIH for 18 years, including a NIDA K05 and a collaborative R01 grant.

Specialties

Board Certification

American Board of Psychiatry & Neurology (Psychiatry)

Perry Renshaw, MD, PhD, MBA, is a graduate of the University of Pennsylvania Perelman School of Medicine in Philadelphia, PA. He also completed his PhD in Biophysics at the University of Pennsylvania and his MBA at the McCallum Graduate School of Business, Bentley College, in Waltham, MA. Dr. Renshaw serves as the Medical Director of the VISN 19 Mental Illness Research, Education and Clinical Center (MIRECC) at the Salt Lake City Veterans Affairs Medical Center. His training as a biophysicist and psychiatrist has led to a primary research interest in the use of multinuclear magnetic resonance spectroscopy (MRS) neuroimaging to identify changes in brain chemistry associated with psychiatric disorders and substance abuse. Over the past 20 years, he has conducted more than 1,000 MRS brain scans of individuals with mood disorders, with the goal of characterizing the cross-sectional and longitudinal alterations in brain chemistry associated with mood disorders and their treatment. As Professor in the Department of Psychiatry, he has a notable publication record having served as an author on more than 300 publications. His research projects have been funded by the NIH for 18 years, including a NIDA K05 and a collaborative R01 grant.

Board Certification and Academic Information

Academic Departments Psychiatry -Professor
Academic Divisions Adult Psychiatry
Board Certification
American Board of Psychiatry & Neurology (Psychiatry)

Education history

Undergraduate Chemistry - Massachusetts Institute of Technology S.B.
Professional Medical Medicine - University of Pennsylvania M.D.
Doctoral Training Biophysics - University of Pennsylvania Ph.D.
Postdoctoral Fellowship Metabolic NMR - University of Pennsylvania Postdoctoral Fellow
Internship Internal Medicine - Brigham and Women's Hospital Intern
Residency Psychiatry - Massachusetts General Hospital Resident
Fellowship Neuroscience - Massachusetts General Hospital Fellow
Graduate Training Business Administration - Bentley University M.B.A.

Selected Publications

Journal Article

  1. Aydin B, Yurt A, Gökmen N, Renshaw P, Olson D, Yildiz A (2016). Trait-related alterations of N-acetylaspartate in euthymic bipolar patients: A longitudinal proton magnetic resonance spectroscopy study. Journal of affective disorders, 206, 315-320.
  2. Kang KD, Han DH, Kim SM, Bae S, Renshaw P (2016). The correlation between cognitive and movement shifting and brain activity in children with ADHD. Journal of attention disorders, 1-10.
  3. Chung US, Han DH, Shin YJ, Renshaw PF (2016). A prosocial online game for social cognition training in adolescents with high-functioning autism: an fMRI study. Neuropsychiatric disease and treatment, 12, 651-60.
  4. Yildiz A, Aydin B, Gökmen N, Yurt A, Cohen B, Keskinoglu P, Öngür D, Renshaw P (2016). Antimanic Treatment With Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study. Biological psychiatry. Cognitive neuroscience and neuroimaging, 1(2), 125-131.
  5. Subramaniam P, Prescot A, McGlade E, Renshaw P, Yurgelun-Todd (2022). Examination of gamma-aminobutyric acid and glutamate-glutamine levels in association with impulsive behavior in adolescent marijuana users. Drug and alcohol dependence, 233, 109326.
  6. Huber RS, Sheth C, Renshaw PF, Yurgelun-Todd DA, McGlade E (2022). Suicide Ideation and Neurocognition Among 9- and 10-Year Old Children in the Adolescent Brain Cognitive Development (ABCD) Study. Archives of suicide research, 26(2), 641-655.
  7. Jeong H, Yoon S, Sung YH, Kim J, Lyoo IK, Yurgelun-Todd DA, Renshaw P (2021). Effects of cytidine-5'-diphosphate choline on gray matter volumes in methamphetamine-dependent patients: A randomized, double-blind, placebo-controlled study. Journal of psychiatric research, 143, 215-221.
  8. Palmer CE, Sheth C, Marshall AT, Adise S, Baker FC, Chang L, Clark DB, Coronado C, Dagher RK, Diaz V, Dowling GJ, Gonzalez MR, Haist F, Herting MM, Huber RS, Jernigan TL, LeBlanc K, Lee K, Lisdahl KM, Neigh G, Patterson MW, Renshaw P, Rhee KE, Tapert S, Thompson WK, Uban K, Sowell ER, Yurgelun-Todd (2021). A Comprehensive Overview of the Physical Health of the Adolescent Brain Cognitive Development Study Cohort at Baseline. Frontiers in pediatrics, 9, 734184.
  9. Han DH, Bae S, Hong J, Kim SM, Son YD, Renshaw (2021). Resting-State fMRI Study of ADHD and Internet Gaming Disorder. Journal of attention disorders, 25(8), 1080-1095.
  10. Li Y, Thompson WK, Reuter C, Nillo R, Jernigan T, Dale A, Sugrue LP, ABCD Consortium., Brown J, Dougherty RF, Rauschecker A, Rudie J, Barch DM, Calhoun V, Hagler D, Hatton S, Tanabe J, Marshall A, Sher KJ, Heeringa S, Hermosillo R, Banich MT, Squeglia L, Bjork J, Zucker R, Neale M, Herting M, Sheth C, Huber R, Reeves G, Hettema JM, Howlett KD, Cloak C, Baskin-Sommers A, Rapuano K, Gonzalez R, Karcher N, Laird A, Baker F, James R, Sowell E, Dick A, Hawes S, Sutherland M, Bagot K, Bodurka J, Breslin F, Morris A, Paulus M, Gray K, Hoffman E, Weiss S, Rajapakse N, Glantz M, Nagel B, Ewing SF, Goldstone A, Pfefferbaum A, Prouty D, Rosenberg M, Bookheimer S, Tapert S, Infante M, Jacobus J, Giedd J, Shilling P, Wade N, Uban K, Haist F, Heyser C, Palmer C, Kuperman J, Hewitt J, Cottler L, Isaiah A, Chang L, Edwards S, Ernst T, Heitzeg M, Puttler L, Sripada C, Iacono W, Luciana M, Clark D, Luna B, Schirda C, Foxe J, Freedman E, Mason M, McGlade E, Renshaw P, Yurgelun-Todd D, Albaugh M, Allgaier N, Chaarani B, Potter A, Ivanova M, Lisdahl K, Do E, Maes H, Bogdan R, Anokhin A, Dosenbach N, Glaser P, Heath A, Casey BJ, Gee D, Garavan HP, Dowling G, Brown (2021). Rates of Incidental Findings in Brain Magnetic Resonance Imaging in Children. JAMA neurology, 78(5), 578-587.
  11. Legarreta MD, Sheth C, Prescot AP, Renshaw PF, McGlade EC, Yurgelun-Todd D (2021). An exploratory proton MRS examination of gamma-aminobutyric acid, glutamate, and glutamine and their relationship to affective aspects of chronic pain. Neuroscience research, 163, 10-17.
  12. Huber RS, Boxer D, Smith CJ, Renshaw PF, Yurgelun-Todd DA, Kondo D (2023). Detailed assessment of suicidal ideation in youth with bipolar disorder versus major depressive disorder. Bipolar disorders, 25(3), 200-208.
  13. Merritt K, McCutcheon RA, Aleman A, Ashley S, Beck K, Block W, Bloemen OJN, Borgan F, Boules C, Bustillo JR, Capizzano AA, Coughlin JM, David A, de la Fuente-Sandoval C, Demjaha A, Dempster K, Do KQ, Du F, Falkai P, Gali'ska-Skok B, Gallinat J, Gasparovic C, Ginestet CE, Goto N, Graff-Guerrero A, Ho BC, Howes O, Jauhar S, Jeon P, Kato T, Kaufmann CA, Kegeles LS, Keshavan MS, Kim SY, King B, Kunugi H, Lauriello J, León-Ortiz P, Liemburg E, Mcilwain ME, Modinos G, Mouchlianitis E, Nakamura J, Nenadic I, Öngür D, Ota M, Palaniyappan L, Pantelis C, Patel T, Plitman E, Posporelis S, Purdon SE, Reichenbach JR, Renshaw PF, Reyes-Madrigal F, Russell BR, Sawa A, Schaefer M, Shungu DC, Smesny S, Stanley JA, Stone J, Szulc A, Taylor R, Thakkar KN, Théberge J, Tibbo PG, van Amelsvoort T, Walecki J, Williamson PC, Wood SJ, Xin L, Yamasue H, McGuire P, Egerton A, 1H-MRS in Schizophrenia Investigator (2023). Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis. Molecular psychiatry,
  14. McGlade EC, Han DH, Kim SM, Shi X, Cline K, Yurgelun-Todd D, Renshaw P (2022). Proton magnetic resonance spectroscopy (MRS) in individuals with internet gaming. Frontiers in psychiatry, 13, 1031947.
  15. Prescot A, Huber R, Kanekar S, Kondo D, Prisciandaro J, Ongur D, Renshaw P (2021). Effect of moderate altitude on human cerebral metabolite levels: A preliminary, multi-site, proton magnetic resonance spectroscopy investigation. Psychiatry research. Neuroimaging, 314, 111314.
  16. Chaarani B, Hahn S, Allgaier N, Adise S, Owens MM, Juliano AC, Yuan DK, Loso H, Ivanciu A, Albaugh MD, Dumas J, Mackey S, Laurent J, Ivanova M, Hagler DJ, Cornejo MD, Hatton S, Agrawal A, Aguinaldo L, Ahonen L, Aklin W, Anokhin AP, Arroyo J, Avenevoli S, Babcock D, Bagot K, Baker FC, Banich MT, Barch DM, Bartsch H, Baskin-Sommers A, Bjork JM, Blachman-Demner D, Bloch M, Bogdan R, Bookheimer SY, Breslin F, Brown S, Calabro FJ, Calhoun V, Casey BJ, Chang L, Clark DB, Cloak C, Constable RT, Constable K, Corley R, Cottler LB, Coxe S, Dagher RK, Dale AM, Dapretto M, Delcarmen-Wiggins R, Dick AS, Do EK, Dosenbach NUF, Dowling GJ, Edwards S, Ernst TM, Fair DA, Fan CC, Feczko E, Feldstein-Ewing SW, Florsheim P, Foxe JJ, Freedman EG, Friedman NP, Friedman-Hill S, Fuemmeler BF, Galvan A, Gee DG, Giedd J, Glantz M, Glaser P, Godino J, Gonzalez M, Gonzalez R, Grant S, Gray KM, Haist F, Harms MP, Hawes S, Heath AC, Heeringa S, Heitzeg MM, Hermosillo R, Herting MM, Hettema JM, Hewitt JK, Heyser C, Hoffman E, Howlett K, Huber RS, Huestis MA, Hyde LW, Iacono WG, Infante MA, Irfanoglu O, Isaiah A, Iyengar S, Jacobus J, James R, Jean-Francois B, Jernigan T, Karcher NR, Kaufman A, Kelley B, Kit B, Ksinan A, Kuperman J, Laird AR, Larson C, LeBlanc K, Lessov-Schlagger C, Lever N, Lewis DA, Lisdahl K, Little AR, Lopez M, Luciana M, Luna B, Madden PA, Maes HH, Makowski C, Marshall AT, Mason MJ, Matochik J, McCandliss BD, McGlade E, Montoya I, Morgan G, Morris A, Mulford C, Murray P, Nagel BJ, Neale MC, Neigh G, Nencka A, Noronha A, Nixon SJ, Palmer CE, Pariyadath V, Paulus MP, Pelham WE, Pfefferbaum D, Pierpaoli C, Prescot A, Prouty D, Puttler LI, Rajapaske N, Rapuano KM, Reeves G, Renshaw PF, Riedel MC, Rojas P, de la Rosa M, Rosenberg MD, Ross MJ, Sanchez M, Schirda C, Schloesser D, Schulenberg J, Sher KJ, Sheth C, Shilling PD, Simmons WK, Sowell ER, Speer N, Spittel M, Squeglia LM, Sripada C, Steinberg J, Striley C, Sutherland MT, Tanabe J, Tapert SF, Thompson W, Tomko RL, Uban KA, Vrieze S, Wade NE, Watts R, Weiss S, Wiens BA, Williams OD, Wilbur A, Wing D, Wolff-Hughes D, Yang R, Yurgelun-Todd DA, Zucker RA, Potter A, Garavan HP, ABCD Consortiu (2021). Baseline brain function in the preadolescents of the ABCD Study. Nature neuroscience, 24(8), 1176-1186.
  17. Kanekar S, Ettaro R, Hoffman MD, Ombach HJ, Brown J, Lynch C, Sheth CS, Renshaw P (2021). Sex-Based Impact of Creatine Supplementation on Depressive Symptoms, Brain Serotonin and SSRI Efficacy in an Animal Model of Treatment-Resistant Depression. International journal of molecular sciences, 22(15),
  18. Merritt K, McGuire PK, Egerton A, 1H-MRS in Schizophrenia Investigators, Aleman A, Block W, Bloemen OJN, Borgan F, Bustillo JR, Capizzano AA, Coughlin JM, De la Fuente-Sandoval C, Demjaha A, Dempster K, Do KQ, Du F, Falkai P, Galinska-Skok B, Gallinat J, Gasparovic C, Ginestet CE, Goto N, Graff-Guerrero A, Ho BC, Howes OD, Jauhar S, Jeon P, Kato T, Kaufmann CA, Kegeles LS, Keshavan M, Kim SY, Kunugi H, Lauriello J, Liemburg EJ, Mcilwain ME, Modinos G, Mouchlianitis ED, Nakamura J, Nenadic I, Öngür D, Ota M, Palaniyappan L, Pantelis C, Plitman E, Posporelis S, Purdon SE, Reichenbach JR, Renshaw PF, Russell BR, Sawa A, Schaefer M, Shungu DC, Smesny S, Stanley JA, Stone JM, Szulc A, Taylor R, Thakkar K, Théberge J, Tibbo PG, van Amelsvoort T, Walecki J, Williamson PC, Wood SJ, Xin L, Yamasue (2021). Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data. JAMA psychiatry, 78(6), 667-681.
  19. Herting MM, Uban KA, Gonzalez MR, Baker FC, Kan EC, Thompson WK, Granger DA, Albaugh MD, Anokhin AP, Bagot KS, Banich MT, Barch DM, Baskin-Sommers A, Breslin FJ, Casey BJ, Chaarani B, Chang L, Clark DB, Cloak CC, Constable RT, Cottler LB, Dagher RK, Dapretto M, Dick AS, Dosenbach N, Dowling GJ, Dumas JA, Edwards S, Ernst T, Fair DA, Feldstein-Ewing SW, Freedman EG, Fuemmeler BF, Garavan H, Gee DG, Giedd JN, Glaser PEA, Goldstone A, Gray KM, Hawes SW, Heath AC, Heitzeg MM, Hewitt JK, Heyser CJ, Hoffman EA, Huber RS, Huestis MA, Hyde LW, Infante MA, Ivanova MY, Jacobus J, Jernigan TL, Karcher NR, Laird AR, LeBlanc KH, Lisdahl K, Luciana M, Luna B, Maes HH, Marshall AT, Mason MJ, McGlade EC, Morris AS, Nagel BJ, Neigh GN, Palmer CE, Paulus MP, Potter AS, Puttler LI, Rajapakse N, Rapuano K, Reeves G, Renshaw PF, Schirda C, Sher KJ, Sheth C, Shilling PD, Squeglia LM, Sutherland MT, Tapert SF, Tomko RL, Yurgelun-Todd D, Wade NE, Weiss SRB, Zucker RA, Sowell E (2021). Correspondence Between Perceived Pubertal Development and Hormone Levels in 9-10 Year-Olds From the Adolescent Brain Cognitive Development Study. Frontiers in endocrinology, 11, 549928.
  20. Huber RS, McGlade EC, Legarreta M, Subramaniam P, Renshaw PF, Yurgelun-Todd D (2021). Cingulate white matter volume and associated cognitive and behavioral impulsivity in Veterans with a history of suicide behavior. Journal of affective disorders, 281, 117-124.
  21. Kang I, Kondo D, Kim J, Lyoo IK, Yurgelun-Todd D, Hwang J, Renshaw P (2021). Elevating the level of hypoxia inducible factor may be a new potential target for the treatment of depression. Medical hypotheses, 146, 110398.
  22. Prisciandaro JJ, Schacht JP, Prescot AP, Brenner HM, Renshaw PF, Brown TR, Anton R (2020). Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment-naive individuals with alcohol use disorder. Addiction biology, 25(6), e12810.
  23. Mastaloudis A, Sheth C, Hester SN, Wood SM, Prescot A, McGlade E, Renshaw PF, Yurgelun-Todd D (2020). Supplementation with a putative calorie restriction mimetic micronutrient blend increases glutathione concentrations and improves neuroenergetics in brain of healthy middle-aged men and women. Free radical biology & medicine, 153, 112-121.
  24. Sheth C, Prescot AP, Legarreta M, Renshaw PF, McGlade E, Yurgelun-Todd (2020). Increased myoinositol in the anterior cingulate cortex of veterans with a history of traumatic brain injury: a proton magnetic resonance spectroscopy study. Journal of neurophysiology, 123(5), 1619-1629.
  25. Bakian AV, Huber RS, Scholl L, Renshaw PF, Kondo (2020). Dietary creatine intake and depression risk among U.S. adults. Translational psychiatry, 10(1), 52.
  26. Yurgelun-Todd DA, Renshaw PF, Goldsmith P, Uz T, Macek T (2020). A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects. Psychopharmacology, 237(2), 317-328.
  27. Hagler DJ Jr, Hatton S, Cornejo MD, Makowski C, Fair DA, Dick AS, Sutherland MT, Casey BJ, Barch DM, Harms MP, Watts R, Bjork JM, Garavan HP, Hilmer L, Pung CJ, Sicat CS, Kuperman J, Bartsch H, Xue F, Heitzeg MM, Laird AR, Trinh TT, Gonzalez R, Tapert SF, Riedel MC, Squeglia LM, Hyde LW, Rosenberg MD, Earl EA, Howlett KD, Baker FC, Soules M, Diaz J, de Leon OR, Thompson WK, Neale MC, Herting M, Sowell ER, Alvarez RP, Hawes SW, Sanchez M, Bodurka J, Breslin FJ, Morris AS, Paulus MP, Simmons WK, Polimeni JR, van der Kouwe A, Nencka AS, Gray KM, Pierpaoli C, Matochik JA, Noronha A, Aklin WM, Conway K, Glantz M, Hoffman E, Little R, Lopez M, Pariyadath V, Weiss SR, Wolff-Hughes DL, DelCarmen-Wiggins R, Feldstein Ewing SW, Miranda-Dominguez O, Nagel BJ, Perrone AJ, Sturgeon DT, Goldstone A, Pfefferbaum A, Pohl KM, Prouty D, Uban K, Bookheimer SY, Dapretto M, Galvan A, Bagot K, Giedd J, Infante MA, Jacobus J, Patrick K, Shilling PD, Desikan R, Li Y, Sugrue L, Banich MT, Friedman N, Hewitt JK, Hopfer C, Sakai J, Tanabe J, Cottler LB, Nixon SJ, Chang L, Cloak C, Ernst T, Reeves G, Kennedy DN, Heeringa S, Peltier S, Schulenberg J, Sripada C, Zucker RA, Iacono WG, Luciana M, Calabro FJ, Clark DB, Lewis DA, Luna B, Schirda C, Brima T, Foxe JJ, Freedman EG, Mruzek DW, Mason MJ, Huber R, McGlade E, Prescot A, Renshaw PF, Yurgelun-Todd DA, Allgaier NA, Dumas JA, Ivanova M, Potter A, Florsheim P, Larson C, Lisdahl K, Charness ME, Fuemmeler B, Hettema JM, Maes HH, Steinberg J, Anokhin AP, Glaser P, Heath AC, Madden PA, Baskin-Sommers A, Constable RT, Grant SJ, Dowling GJ, Brown SA, Jernigan TL, Dale A (2019). Image processing and analysis methods for the Adolescent Brain Cognitive Development Study. NeuroImage, 202, 116091.
  28. Hwang J, DeLisi LE, Öngür D, Riley C, Zuo C, Shi X, Sung YH, Kondo D, Kim TS, Villafuerte R, Smedberg D, Yurgelun-Todd D, Renshaw P (2019). Cerebral bioenergetic differences measured by phosphorus-31 magnetic resonance spectroscopy between bipolar disorder and healthy subjects living in two different regions suggesting possible effects of altitude. Psychiatry and clinical neurosciences, 73(9), 581-589.
  29. Prisciandaro JJ, Schacht JP, Prescot AP, Brenner HM, Renshaw PF, Brown TR, Anton R (2019). Evidence for a unique association between fronto-cortical glycine levels and recent heavy drinking in treatment naïve individuals with alcohol use disorder. Neuroscience letters, 706, 207-210.
  30. Ombach HJ, Scholl LS, Bakian AV, Renshaw KT, Sung YH, Renshaw PF, Kanekar (2019). Association between altitude, prescription opioid misuse, and fatal overdoses. Addictive behaviors reports, 9, 100167.
  31. Sabic H, Kious B, Boxer D, Fitzgerald C, Riley C, Scholl L, McGlade E, Yurgelun-Todd D, Renshaw PF, Kondo D (2019). Effect of Altitude on Veteran Suicide Rates. High altitude medicine & biology, 20(2), 171-177.
  32. Huber RS, Subramaniam P, Kondo DG, Shi X, Renshaw PF, Yurgelun-Todd D (2019). Reduced lateral orbitofrontal cortex volume and suicide behavior in youth with bipolar disorder. Bipolar disorders, 21(4), 321-329.
  33. Sheth C, Prescot AP, Legarreta M, Renshaw PF, McGlade E, Yurgelun-Todd (2019). Reduced gamma-amino butyric acid (GABA) and glutamine in the anterior cingulate cortex (ACC) of veterans exposed to trauma. Journal of affective disorders, 248, 166-174.
  34. Prisciandaro JJ, Schacht JP, Prescot AP, Renshaw PF, Brown TR, Anton R (2019). Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers. Alcoholism, clinical and experimental research, 43(2), 221-226.
  35. Han DH, Yoo M, Renshaw PF, Petry N (2018). A cohort study of patients seeking Internet gaming disorder treatment. Journal of behavioral addictions, 7(4), 930-938.
  36. Curtin K, Fleckenstein AE, Keeshin BR, Yurgelun-Todd DA, Renshaw PF, Smith KR, Hanson G (2018). Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder. Neuropsychopharmacology, 43(13), 2548-2555.
  37. Prescot AP, Prisciandaro JJ, Miller SR, Ingenito G, Kondo DG, Renshaw P (2018). Two-Dimensional Proton Magnetic Resonance Spectroscopy versus J-Editing for GABA Quantification in Human Brain: Insights from a GABA-Aminotransferase Inhibitor Study. Scientific reports, 8(1), 13200.
  38. Kanekar S, Sheth CS, Ombach HJ, Olson PR, Bogdanova OV, Petersen M, Renshaw CE, Sung YH, D'Anci KE, Renshaw P (2018). Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline. Pharmacology, biochemistry, and behavior, 170, 25-35.
  39. Sheth C, Prescot A, Bueler E, DiMuzio J, Legarreta M, Renshaw PF, Yurgelun-Todd D, McGlade (2018). Alterations in anterior cingulate cortex myoinositol and aggression in veterans with suicidal behavior: A proton magnetic resonance spectroscopy study. Psychiatry research. Neuroimaging, 276, 24-32.
  40. Yoon S, Kim J, Musen G, Renshaw PF, Hwang J, Bolo NR, Kim JE, Simonson DC, Weinger K, Ryan CM, Lyoo IK, Jacobson A (2018). Prefronto-temporal white matter microstructural alterations 20¿years after the diagnosis of type 1 diabetes mellitus. Pediatric diabetes, 19(3), 478-485.
  41. Kang KD, Han DH, Kim SM, Bae S, Renshaw P (2018). The Correlation Between Cognitive and Movement Shifting and Brain Activity in Children With ADHD. Journal of attention disorders, 22(7), 661-670.
  42. Sheth C, Ombach H, Olson P, Renshaw PF, Kanekar (2018). Increased Anxiety and Anhedonia in Female Rats Following Exposure to Altitude. High altitude medicine & biology, 19(1), 81-90.
  43. Prescot AP, Miller SR, Ingenito G, Huber RS, Kondo DG, Renshaw P (2018). In Vivo Detection of CPP-115 Target Engagement in Human Brain. Neuropsychopharmacology, 43(3), 646-654.
  44. Prescot A, Sheth C, Legarreta M, Renshaw PF, McGlade E, Yurgelun-Todd (2018). Altered Cortical GABA in Female Veterans with Suicidal Behavior: Sex Differences and Clinical Correlates. Chronic stress (Thousand Oaks, Calif.), 2,
  45. Huber RS, Kondo DG, Shi XF, Prescot AP, Clark E, Renshaw PF, Yurgelun-Todd D (2018). Relationship of executive functioning deficits to N-acetyl aspartate (NAA) and gamma-aminobutyric acid (GABA) in youth with bipolar disorder. Journal of affective disorders, 225, 71-78.
  46. Kim JE, Kim GH, Hwang J, Kim JY, Renshaw PF, Yurgelun-Todd DA, Kim B, Kang I, Jeon S, Ma J, Lyoo IK, Yoon (2018). Metabolic alterations in the anterior cingulate cortex and related cognitive deficits in late adolescent methamphetamine users. Addiction biology, 23(1), 327-336.
  47. Bae S, Han DH, Jung J, Nam KC, Renshaw P (2017). Comparison of brain connectivity between Internet gambling disorder and Internet gaming disorder: A preliminary study. Journal of behavioral addictions, 6(4), 505-515.
  48. Prisciandaro JJ, Tolliver BK, Prescot AP, Brenner HM, Renshaw PF, Brown TR, Anton R (2017). Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence. Translational psychiatry, 7(7), e1163.
  49. Son YD, Han DH, Kim SM, Min KJ, Renshaw P (2017). A functional connectivity comparison between attention deficit hyperactivity disorder and bipolar disorder in medication-naïve adolescents with mood fluctuation and attention problems. Psychiatry research. Neuroimaging, 263, 1-7.
  50. Han DH, Kim SM, Bae S, Renshaw PF, Anderson J (2017). Brain connectivity and psychiatric comorbidity in adolescents with Internet gaming disorder. Addiction biology, 22(3), 802-812.
  51. Harper DG, Jensen JE, Ravichandran C, Perlis RH, Fava M, Renshaw PF, Iosifescu D (2017). Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression. Neuropsychopharmacology, 42(4), 876-885.
  52. Yoon S, Kim JE, Hwang J, Kim TS, Kang HJ, Namgung E, Ban S, Oh S, Yang J, Renshaw PF, Lyoo I (2016). Effects of Creatine Monohydrate Augmentation on Brain Metabolic and Network Outcome Measures in Women With Major Depressive Disorder. Biological psychiatry, 80(6), 439-447.
  53. Bae S, Han DH, Kim SM, Shi X, Renshaw P (2016). Neurochemical correlates of internet game play in adolescents with attention deficit hyperactivity disorder: A proton magnetic resonance spectroscopy (MRS) study. Psychiatry research. Neuroimaging, 254, 10-7.
  54. Kondo DG, Forrest LN, Shi X, Sung YH, Hellem TL, Huber RS, Renshaw P (2016). Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression. Amino acids, 48(8), 1941-54.
  55. Jeong BS, Han DH, Kim SM, Lee SW, Renshaw P (2016). White matter connectivity and Internet gaming disorder. Addiction biology, 21(3), 732-42.
  56. Han DH, Kim SM, Bae S, Renshaw PF, Anderson J (2016). A failure of suppression within the default mode network in depressed adolescents with compulsive internet game play. Journal of affective disorders, 194, 57-64.
  57. Prisciandaro JJ, Schacht JP, Prescot AP, Renshaw PF, Brown TR, Anton R (2016). Associations Between Recent Heavy Drinking and Dorsal Anterior Cingulate N-Acetylaspartate and Glutamate Concentrations in Non-Treatment-Seeking Individuals with Alcohol Dependence. Alcoholism, clinical and experimental research, 40(3), 491-6.
  58. Lyoo IK, Yoon S, Kim TS, Lim SM, Choi Y, Kim JE, Hwang J, Jeong HS, Cho HB, Chung YA, Renshaw P (2015). Predisposition to and effects of methamphetamine use on the adolescent brain. Molecular psychiatry, 20(12), 1516-24.
  59. Shi XF, Carlson PJ, Sung YH, Fiedler KK, Forrest LN, Hellem TL, Huber RS, Kim SE, Zuo C, Jeong EK, Renshaw PF, Kondo D (2015). Decreased brain PME/PDE ratio in bipolar disorder: a preliminary (31) P magnetic resonance spectroscopy study. Bipolar disorders, 17(7), 743-52.
  60. Bogdanov VB, Viganò A, Noirhomme Q, Bogdanova OV, Guy N, Laureys S, Renshaw PF, Dallel R, Phillips C, Schoenen (2015). Cerebral responses and role of the prefrontal cortex in conditioned pain modulation: an fMRI study in healthy subjects. Behavioural brain research, 281, 187-98.
  61. Kanekar S, Bogdanova OV, Olson PR, Sung YH, D'Anci KE, Renshaw P (2015). Hypobaric hypoxia induces depression-like behavior in female Sprague-Dawley rats, but not in males. High altitude medicine & biology, 16(1), 52-60.
  62. Han JW, Han DH, Bolo N, Kim B, Kim BN, Renshaw P (2015). Differences in functional connectivity between alcohol dependence and internet gaming disorder. Addictive behaviors, 41, 12-9.
  63. Hellem TL, Sung YH, Shi XF, Pett MA, Latendresse G, Morgan J, Huber RS, Kuykendall D, Lundberg KJ, Renshaw P (2015). Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study. Journal of dual diagnosis, 11(3-4), 189-202.
  64. Plante DT, Trksak GH, Jensen JE, Penetar DM, Ravichandran C, Riedner BA, Tartarini WL, Dorsey CM, Renshaw PF, Lukas SE, Harper D (2014). Gray matter-specific changes in brain bioenergetics after acute sleep deprivation: a 31P magnetic resonance spectroscopy study at 4 Tesla. Sleep, 37(12), 1919-27.
  65. Huber RS, Kim N, Renshaw CE, Renshaw PF, Kondo D (2014). Relationship between altitude and lithium in groundwater in the United States of America: results of a 1992-2003 study. Geospatial health, 9(1), 231-5.
  66. Darlington TM, Pimentel R, Smith K, Bakian AV, Jerominski L, Cardon J, Camp NJ, Callor WB, Grey T, Singleton M, Yandell M, Renshaw PF, Yurgelun-Todd DA, Gray D, Coon (2014). Identifying rare variants for genetic risk through a combined pedigree and phenotype approach: application to suicide and asthma. Translational psychiatry, 4(10), e471.
  67. Jeong EK, Sung YH, Kim SE, Zuo C, Shi X, Mellon EA, Renshaw P (2011). Measurement of creatine kinase reaction rate in human brain using magnetization transfer image-selected in vivo spectroscopy (MT-ISIS) and a volume ³¹P/¹H radiofrequency coil in a clinical 3-T MRI system. NMR in biomedicine, 24(7), 765-70.
  68. Agarwal N, Sung YH, Jensen JE, daCunha G, Harper D, Olson D, Renshaw P (2010). Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T. Bipolar disorders, 12(8), 825-33.
  69. Saleh MG, Prescot A, Chang L, Cloak C, Cunningham E, Subramaniam P, Renshaw PF, Yurgelun-Todd D, Zöllner HJ, Roberts TPL, Edden RAE, Ernst (2023). Glutamate measurements using edited MRS. Magnetic resonance in medicine, 91(4), 1314-1322.
  70. Ma J, McGlade EC, Huber RS, Lyoo IK, Renshaw PF, Yurgelun-Todd D (2023). Overweight/Obesity-related microstructural alterations of the fimbria-fornix in the ABCD study: The role of aerobic physical activity. PloS one, 18(7), e0287682.
  71. Joo Y, Lee S, Hwang J, Kim J, Cheon YH, Lee H, Kim S, Yurgelun-Todd DA, Renshaw PF, Yoon S, Lyoo I (2023). Differential alterations in brain structural network organization during addiction between adolescents and adults. Psychological medicine, 53(9), 3805-3816.
  72. Sheth C, Huber RS, Renshaw PF, Yurgelun-Todd DA, McGlade E (2023). Mild Traumatic Brain Injury and Behavior and Sleep Among 9- and 10-Year Old Children: Initial Findings From the Adolescent Brain Cognitive Development (ABCD) Study. The Journal of early adolescence, 43(6), 720-745.
  73. Ma J, Subramaniam P, Yancey JR, Farrington AA, McGlade EC, Renshaw PF, Yurgelun-Todd DA (2024). Elevated circulating soluble interleukin-2 receptor (sCD25) level is associated with prefrontal excitatory-inhibitory imbalance in individuals with chronic pain: A proton MRS study. Brain, behavior, and immunity, (120), 1-9.
  74. Han ES, Park Y, Yurgelun-Todd D, Renshaw PF, Han D (2024). Comparing the effectiveness of game literacy education and game coding education in improving problematic internet gaming. Frontiers in psychiatry, 15(1377231),
  75. Yancey JR, Ma J, Subramaniam P, Carson CN, McGlade EC, Yurgelun-Todd DA, Renshaw P (2024). Creatine concentration in the anterior cingulate cortex is associated with greater stress recovery from traumatic events: Preliminary evidence from a US Veteran sample. Journal of affective disorders, (355), 115-121.
  76. Huber RS, Subramaniam P, Heinrich L, Boxer DJ, Shi X, Schreiner MW, Renshaw PF, Yurgelun-Todd DA, Kondo D (2025). Cingulate cortex cortical thickness associated with non-suicidal self-injury and suicide risk in youth with mood disorders. Journal of affective disorders, 381, 518-524.
  77. Ma J, Prescot AP, Subramaniam P, McGlade EC, Renshaw PF, Yurgelun-Todd D (2025). Weekly sleep loss is associated with reduced cortical glutathione and antioxidant capacity in adolescents. Sleep, 48(11),
  78. Yancey JR, Subramaniam P, Ma J, Carson CN, Roberts KE, McGlade EC, Renshaw PF, Yurgelun-Todd D (2025). Glutamine Metabolite Ratios are Related to Thwarted Belongingness and Perceived Burdensomeness: Preliminary Evidence from a Veteran Sample with and Without History of Suicidal Ideation. Chronic stress (Thousand Oaks, Calif.), 9, 24705470251385745.
  79. Rhee KE, Thaweethai T, Pant DB, Stein CR, Salisbury AL, Kinser PA, Kleinman LC, Gallagher R, Warburton D, Mohandas S, Snowden JN, Stockwell MS, Tantisira KG, Flaherman VJ, Teufel RJ, Castro L, Chung A, Espinoza Esparza J, Hockett CW, Isidoro-Chino M, Krishnan A, McCormack LA, Nabower AM, Nahin ER, Rosas JM, Siddiqui S, Szmuszkovicz JR, Vangeepuram N, Zimmerman E, Brown HE, Carmilani M, Coombs K, Fisher L, Witvliet MG, Wood JC, Milner JD, Rosenzweig EB, Irby K, Karlson EW, Qian Z, Lamendola-Essel MF, Hasson DC, Katz SD, Yin HS, Foulkes AS, Gross RS, RECOVER-Pediatrics Group; and the ABCD-RECOVER Group; for the RECOVER-Pediatrics Consortium, Aschner JL, Atz AM, Banerjee D, Bogie A, Bukulmez H, Clouser K, Cottrell LA, Cowan K, D'Sa VA, Dozor AJ, Elliott AJ, Faustino EVS, Fiks AG, Gaur S, Gennaro ML, Gordon ST, Hasan UN, Hester CM, Hogan AH, Hsia DS, Kaelber DC, Kosut JS, Krishnan S, McCulloh RJ, Michelow IC, Nolan SM, Oliveira CR, Pace WD, Palumbo P, Raissy H, Reyes A, Ross JL, Salazar JC, Selvarangan R, Stevenson MD, Werzberger A, Westfall JM, Zani K, Zempsky WT, Chan J, Metz TD, Newburger JW, Truong DT, Feldman CH, Aupperle R, Baker FC, Banich MT, Barch DM, Baskin-Sommers A, Bjork JM, Dapretto M, Brown SA, Casey BJ, Chang L, Clark DB, Dale AM, Ernst TM, Fair DA, Feldstein Ewing SW, Foxe JJ, Freedman EG, Friedman NP, Garavan H, Gee DG, Gonzalez R, Gray KM, Heitzeg MM, Herting MM, Jacobus J, Laird AR, Larson CL, Lisdahl KM, Luciana M, Luna B, Madden PAF, McGlade EC, Müller-Oehring EM, Nagel BJ, Neale MC, Paulus MP, Potter AS, Renshaw PF, Sowell ER, Squeglia LM, Uddin LQ, Wilson S, Yurgelun-Todd D (2026). Social Determinants of Health and Pediatric Long COVID in the US. JAMA pediatrics, 180(3), 275-287.
  80. Boxer DJ, Sung YH, Nunez NA, Fitzgerald CE, Renshaw PF, Kondo D (2024). Exploring the Link between Altitude of Residence and Smoking Patterns in the United States. International journal of environmental research and public health, 21(2),

Review

  1. Smith CJ, Renshaw P, Yurgelun-Todd D, Sheth (2022). Acute and chronic neuropsychiatric symptoms in novel coronavirus disease 2019 (COVID-19) patients: A qualitative review. Frontiers in public health, 10, 772335.
  2. Kious BM, Kondo DG, Renshaw P (2019). Creatine for the Treatment of Depression. Biomolecules, 9(9),
  3. Kious BM, Kondo DG, Renshaw P (2018). Living High and Feeling Low: Altitude, Suicide, and Depression. Harvard review of psychiatry, 26(2), 43-56.
  4. Riley CA, Renshaw P (2018). Brain choline in major depression: A review of the literature. Psychiatry research. Neuroimaging, 271, 142-153.
  5. Gould TD, Georgiou P, Brenner LA, Brundin L, Can A, Courtet P, Donaldson ZR, Dwivedi Y, Guillaume S, Gottesman II, Kanekar S, Lowry CA, Renshaw PF, Rujescu D, Smith EG, Turecki G, Zanos P, Zarate CA Jr, Zunszain PA, Postolache T (2017). Animal models to improve our understanding and treatment of suicidal behavior. Translational psychiatry, 7(4), e1092.
  6. Hellem T, Shi X, Latendresse G, Renshaw P (2015). The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the Literature. Journal of the American Psychiatric Nurses Association, 21(4), 244-75.
  7. Hellem TL, Lundberg KJ, Renshaw P (2015). A review of treatment options for co-occurring methamphetamine use disorders and depression. Journal of addictions nursing, 26(1), 14-23; quiz E1.
  8. Ma J, Lyoo IK, Renshaw PF, Yurgelun-Todd D (2023). Effect of cannabinoids on brain metabolites: A review of animal and human studies. Experimental and clinical psychopharmacology, 31(1), 248-262.
  9. Han ES, Yancey JR, Yurgelun-Todd DA, Kondo DG, Boxer DJ, Renshaw P (2025). The role of brain creatine in behavioral health conditions. Frontiers in psychiatry, 16, 1667639.

News & Podcasts

News

Podcasts